Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashique Rafique

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 23, 2022
Combinatorial Inhibition of Myostatin and Activin A Improves Femoral Bone Properties in the G610C Mouse Model of Osteogenesis ImperfectaCatherine L Omosule, Dominique Joseph, Brooke Weiler, et al.
Angiogenesis|February 4, 2012
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabNicholas Papadopoulos, Joel Martin, Qin Ruan, et al.
Bioanalysis|March 17, 2022
Assay pH and critical reagent optimization in measuring concentrations of a monoclonal antibody and its targetJihua Chen, Kimberly Kendra, Stacey Shank, et al.
Endocrinology|May 29, 2015
Glucagon Receptor Blockade With a Human Antibody Normalizes Blood Glucose in Diabetic Mice and MonkeysHaruka Okamoto, Jinrang Kim, JohnPaul Aglione, et al.
Nature Communications|April 26, 2023
Structural analysis of cancer-relevant TCR-CD3 and peptide-MHC complexes by cryoEMKei Saotome, Drew Dudgeon, Kiersten Colotti, et al.
Molecular Cancer Therapeutics|January 22, 2017
Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCsJulian Andreev, Nithya Thambi, Andres E Perez Bay, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 29, 2020
Impact of Genetic and Pharmacologic Inhibition of Myostatin in a Murine Model of Osteogenesis ImperfectaCatherine L Omosule, Victoria L Gremminger, Ashley M Aguillard, et al.
Journal of Clinical Pharmacology|December 14, 2020
Differential Binding of Sarilumab and Tocilizumab to IL-6Rα and Effects of Receptor Occupancy on Clinical ParametersChristine Xu, Ashique Rafique, Terra Potocky, et al.
Skeletal Muscle|October 13, 2015
Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged miceEsther Latres, Jeffrey Pangilinan, Lawrence Miloscio, et al.
Cell Reports Methods|August 3, 2023
TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cellsSeblewongel Asrat, Joseph C Devlin, Andrea Vecchione, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 23, 2022
Combinatorial Inhibition of Myostatin and Activin A Improves Femoral Bone Properties in the G610C Mouse Model of Osteogenesis ImperfectaCatherine L Omosule, Dominique Joseph, Brooke Weiler, et al.
Angiogenesis|February 4, 2012
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabNicholas Papadopoulos, Joel Martin, Qin Ruan, et al.
Bioanalysis|March 17, 2022
Assay pH and critical reagent optimization in measuring concentrations of a monoclonal antibody and its targetJihua Chen, Kimberly Kendra, Stacey Shank, et al.
Endocrinology|May 29, 2015
Glucagon Receptor Blockade With a Human Antibody Normalizes Blood Glucose in Diabetic Mice and MonkeysHaruka Okamoto, Jinrang Kim, JohnPaul Aglione, et al.
Nature Communications|April 26, 2023
Structural analysis of cancer-relevant TCR-CD3 and peptide-MHC complexes by cryoEMKei Saotome, Drew Dudgeon, Kiersten Colotti, et al.
Molecular Cancer Therapeutics|January 22, 2017
Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCsJulian Andreev, Nithya Thambi, Andres E Perez Bay, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 29, 2020
Impact of Genetic and Pharmacologic Inhibition of Myostatin in a Murine Model of Osteogenesis ImperfectaCatherine L Omosule, Victoria L Gremminger, Ashley M Aguillard, et al.
Journal of Clinical Pharmacology|December 14, 2020
Differential Binding of Sarilumab and Tocilizumab to IL-6Rα and Effects of Receptor Occupancy on Clinical ParametersChristine Xu, Ashique Rafique, Terra Potocky, et al.
Skeletal Muscle|October 13, 2015
Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged miceEsther Latres, Jeffrey Pangilinan, Lawrence Miloscio, et al.
Cell Reports Methods|August 3, 2023
TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cellsSeblewongel Asrat, Joseph C Devlin, Andrea Vecchione, et al.
Pageof 5